Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Rogler

Showing results (351-360 of 547) with videos related to

Pageof 55
Sort By:
Inflammatory Bowel Diseases|August 20, 2016
Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with FibrosisLaurence Goffin, Stefania Fagagnini, Alain Vicari, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2005
Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patientsEmma E Furth, Jian Li, Enkhtsetseg Purev, et al.
Gut|February 5, 2013
Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's diseaseAna Gutiérrez, Michael Scharl, Laura Sempere, et al.
Journal of Crohn'S & Colitis|January 22, 2026
Association between endo-histological outcomes and colonic mucosal transcriptomic profiles in patients with ulcerative colitis receiving filgotinibFernando Magro, Gerhard Rogler, Brian G Feagan, et al.
Inflammatory Bowel Diseases|October 19, 2016
Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's DiseaseFrauke Degenhardt, Andrea Dirmeier, Rocio Lopez, et al.
Inflammatory Bowel Diseases|August 29, 2009
Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's diseaseJohanna Weigert, Florian Obermeier, Markus Neumeier, et al.
Swiss Medical Weekly|June 14, 2024
Bone health in patients with inflammatory bowel diseaseAndrea S Kreienbuehl, Gerhard Rogler, Burri Emanuel, et al.
The American Journal of Gastroenterology|August 28, 2013
Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rateAlain M Schoepfer, Mohamed-Ali Dehlavi, Nicolas Fournier, et al.
United European Gastroenterology Journal|October 14, 2016
Prediction of low bone mineral density in patients with inflammatory bowel diseasesSolvey Schüle, Jean-Benoît Rossel, Diana Frey, et al.
Inflammatory Intestinal Diseases|December 14, 2020
A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative ColitisHeinfried H Radeke, Jürgen Stein, Gert Van Assche, et al.
Pageof 55

Showing results (351-360 of 547) with videos related to

Sort By:
Pageof 55
Inflammatory Bowel Diseases|August 20, 2016
Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with FibrosisLaurence Goffin, Stefania Fagagnini, Alain Vicari, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2005
Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patientsEmma E Furth, Jian Li, Enkhtsetseg Purev, et al.
Gut|February 5, 2013
Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's diseaseAna Gutiérrez, Michael Scharl, Laura Sempere, et al.
Journal of Crohn'S & Colitis|January 22, 2026
Association between endo-histological outcomes and colonic mucosal transcriptomic profiles in patients with ulcerative colitis receiving filgotinibFernando Magro, Gerhard Rogler, Brian G Feagan, et al.
Inflammatory Bowel Diseases|October 19, 2016
Serologic Anti-GP2 Antibodies Are Associated with Genetic Polymorphisms, Fibrostenosis, and Need for Surgical Resection in Crohn's DiseaseFrauke Degenhardt, Andrea Dirmeier, Rocio Lopez, et al.
Inflammatory Bowel Diseases|August 29, 2009
Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's diseaseJohanna Weigert, Florian Obermeier, Markus Neumeier, et al.
Swiss Medical Weekly|June 14, 2024
Bone health in patients with inflammatory bowel diseaseAndrea S Kreienbuehl, Gerhard Rogler, Burri Emanuel, et al.
The American Journal of Gastroenterology|August 28, 2013
Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rateAlain M Schoepfer, Mohamed-Ali Dehlavi, Nicolas Fournier, et al.
United European Gastroenterology Journal|October 14, 2016
Prediction of low bone mineral density in patients with inflammatory bowel diseasesSolvey Schüle, Jean-Benoît Rossel, Diana Frey, et al.
Inflammatory Intestinal Diseases|December 14, 2020
A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative ColitisHeinfried H Radeke, Jürgen Stein, Gert Van Assche, et al.
Pageof 55